SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-07-08 17:31
Tx date 2024-06-26 		$NPTH
NeuPath Health Inc. 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+32,979 vol 		123,118
Filed 2024-07-08 17:30
Tx date 2024-06-26 		$NPTH
NeuPath Health Inc. 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
57 - Exercise of rights 		$-6,430.905
-32,979 vol
$0.195 each 		0
Filed 2024-03-08 17:38
Tx date 2024-03-04 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-35,000 vol 		643,021
Filed 2024-03-07 11:49
Tx date 2024-03-07 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$10,000
+20,000 vol
$0.50 each 		1,003,296
Filed 2023-09-15 17:24
Tx date 2023-09-12 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+255,000 vol 		678,021
Filed 2023-06-16 12:40
Tx date 2023-06-15 		$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
56 - Grant of rights
+32,979 vol 		32,979
Filed 2023-06-16 12:38
Tx date 2023-06-15 		$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$15,829
+98,935 vol
$0.16 each 		223,843
Filed 2023-06-09 13:15
Tx date 2023-06-07 		$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$2,083
+13,889 vol
$0.15 each 		90,139
Filed 2023-06-09 13:15
Tx date 2023-06-07 		$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
57 - Exercise of rights
-13,889 vol 		0
Filed 2022-11-19 11:41
Tx date 2022-11-15 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+85,000 vol 		423,021
Filed 2022-11-16 19:56
Tx date 2022-11-15 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$19,400
+40,000 vol
$0.485 each 		983,296
Filed 2022-07-14 21:06
Tx date 2022-02-27 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-4,000 vol 		1,750
Filed 2022-07-13 13:47
Tx date 2022-06-16 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
38 - Redemption, retraction, cancellation, repurchase
-1,750 vol 		4,000
Filed 2022-07-12 19:24
Tx date 2022-07-12 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$18,600
+30,000 vol
$0.62 each 		943,296
Filed 2022-07-12 19:17
Tx date 2022-07-11 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$15,190
+24,500 vol
$0.62 each 		913,296
Filed 2022-07-12 19:16
Tx date 2022-07-11 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,500
+7,500 vol
$0.60 each 		888,796
Filed 2022-06-29 15:50
Tx date 2022-05-31 		$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
56 - Grant of rights 		$6,250
+13,889 vol
$0.45 each 		13,889
Filed 2022-06-29 15:49
Tx date 2022-05-31 		$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+41,666 vol 		124,908
Filed 2021-11-19 20:33
Tx date 2021-11-15 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+85,000 vol 		1,277,200
Filed 2021-11-01 19:27
Tx date 2021-11-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$33,320
+34,000 vol
$0.98 each 		881,296
Filed 2021-11-01 19:26
Tx date 2021-11-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$26,600
+28,000 vol
$0.95 each 		847,296
Filed 2021-11-01 19:25
Tx date 2021-11-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,290
+3,500 vol
$0.94 each 		819,296
Filed 2021-11-01 19:24
Tx date 2021-11-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$34,410
+37,000 vol
$0.93 each 		815,796
Filed 2021-11-01 19:23
Tx date 2021-11-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,300
+2,500 vol
$0.92 each 		778,796
Filed 2021-09-16 09:55
Tx date 2021-09-09 		$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+6,250 vol 		76,250
Filed 2021-09-16 09:53
Tx date 2021-09-09 		$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
57 - Exercise of rights
-6,250 vol 		0
Filed 2021-09-01 11:22
Tx date 2021-08-31 		$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,600
+20,000 vol
$0.63 each 		70,000
Filed 2021-08-05 18:02
Tx date 2021-08-04 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,750
+12,500 vol
$1.02 each 		776,296
Filed 2021-07-15 19:57
Tx date 2021-07-13 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$14,280
+4,000 vol
$3.57 each 		763,796
Filed 2021-07-04 17:20
Tx date 2021-06-30 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$14,800
+4,000 vol
$3.70 each 		759,796
Filed 2021-06-06 16:11
Tx date 2021-06-02 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately 		$205,506
+46,458 vol
$4.42 each 		126,100
Filed 2021-06-06 16:09
Tx date 2021-06-02 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$2,637,909
+596,340 vol
$4.42 each 		830,796
Filed 2021-06-06 16:02
Tx date 2021-06-03 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-300,300
-75,000 vol
$4.00 each 		755,796
Filed 2021-03-06 12:45
Tx date 2021-03-03 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately 		$38,861
+7,546 vol
$5.15 each 		79,642
Filed 2021-03-06 12:44
Tx date 2021-03-03 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$153,171
+29,742 vol
$5.15 each 		234,456
Filed 2021-03-03 20:13
Tx date 2021-03-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately 		$116,210
+21,968 vol
$5.29 each 		72,096
Filed 2021-03-03 20:12
Tx date 2021-03-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$457,987
+86,576 vol
$5.29 each 		204,714
Filed 2021-02-27 16:55
Tx date 2021-02-23 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately 		$130,541
+20,461 vol
$6.38 each 		50,128
Filed 2021-02-27 16:54
Tx date 2021-02-23 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$514,470
+80,638 vol
$6.38 each 		118,138
Filed 2021-01-15 18:44
Tx date 2021-01-11 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+513,200 vol 		1,192,200
Filed 2020-12-17 18:23
Tx date 2020-12-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation
-51,750 vol 		5,750
Filed 2020-12-17 18:21
Tx date 2020-12-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
37 - Stock split or consolidation
-6,111,000 vol 		679,000
Filed 2020-12-17 18:20
Tx date 2020-12-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-3,042,185 vol 		338,021
Filed 2020-12-17 18:19
Tx date 2020-12-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-266,999 vol 		29,667
Filed 2020-12-17 18:17
Tx date 2020-12-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-337,500 vol 		37,500
Filed 2020-09-24 13:28
Tx date 2020-09-24 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$25,500
+75,000 vol
$0.34 each 		375,000
Filed 2020-09-04 16:44
Tx date 2020-09-01 		$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
56 - Grant of rights 		$5,437
+6,250 vol
$0.87 each 		6,250
Filed 2020-09-04 16:43
Tx date 2019-11-26 		$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-04 16:42
Tx date 2020-09-01 		$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$16,312
+18,750 vol
$0.87 each 		83,242
Filed 2020-06-26 15:25
Tx date 2020-06-25 		$KHV
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-257,966 vol 		64,492
Filed 2020-06-26 15:25
Tx date 2020-06-25 		$KHV
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-200,000 vol 		50,000
Filed 2020-06-06 13:57
Tx date 2020-06-04 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-135,000
-225,000 vol
$0.60 each 		300,000
Filed 2020-06-06 13:57
Tx date 2020-06-03 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-156,997.50
-259,500 vol
$0.60 each 		525,000
Filed 2020-06-06 13:55
Tx date 2020-06-02 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,300
-15,500 vol
$0.60 each 		784,500
Filed 2020-06-06 13:55
Tx date 2020-06-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-762,500
-1,250,000 vol
$0.61 each 		800,000
Filed 2020-06-06 13:52
Tx date 2020-06-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$145,000
+1,000,000 vol
$0.145 each 		2,050,000
Filed 2020-06-06 13:51
Tx date 2020-06-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$247,500
+750,000 vol
$0.33 each 		1,050,000
Filed 2020-06-06 13:49
Tx date 2020-06-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-145,000
-1,000,000 vol
$0.145 each 		3,380,206
Filed 2020-06-06 13:47
Tx date 2020-06-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-247,500
-750,000 vol
$0.33 each 		4,380,206
Filed 2020-04-09 13:28
Tx date 2020-04-09 		$
Klinik Health Ventures Corp. 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+89,958 vol 		322,458
Filed 2019-12-03 15:16
Tx date 2019-12-03 		$
Klinik Health Ventures Corp. 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+232,500 vol 		232,500
Filed 2019-12-03 15:15
Tx date 2019-11-26 		$
Klinik Health Ventures Corp. 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-12-03 15:15
Tx date 2019-11-26 		$
Klinik Health Ventures Corp. 		Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		250,000
Filed 2019-11-28 13:19
Tx date 2019-11-28 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+2,040,000 vol 		6,790,000
Filed 2019-08-14 14:09
Tx date 2019-08-13 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus 		$5,250
+17,500 vol
$0.30 each 		57,500
Filed 2019-08-14 14:07
Tx date 2019-08-13 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus 		$10,500
+35,000 vol
$0.30 each 		300,000
Filed 2019-06-03 12:30
Tx date 2019-06-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Warrants
55 - Expiration of warrants
-180,000 vol 		0
Filed 2019-05-13 15:17
Tx date 2019-05-13 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$11,900
+35,000 vol
$0.34 each 		265,000
Filed 2019-02-27
Tx date 2019-02-25 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus 		$20,000
+80,000 vol
$0.25 each 		230,000
Filed 2019-02-27
Tx date 2013-06-10 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-02-27
Tx date 2019-02-25 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus 		$10,000
+40,000 vol
$0.25 each 		40,000
Filed 2018-11-28
Tx date 2018-11-27 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,500
+50,000 vol
$0.25 each 		150,000
Filed 2018-10-05
Tx date 2013-06-10 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2018-10-05
Tx date 2018-10-03 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
97 - Other
+4,750,000 vol 		4,750,000
Filed 2018-09-19
Tx date 2018-09-19 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$26,000
+100,000 vol
$0.26 each 		100,000
Filed 2018-04-26
Tx date 2018-04-23 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
40 - Short sale 		$-101,015
-227,000 vol
$0.445 each 		-227,000
Filed 2018-04-26
Tx date 2018-04-23 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
40 - Short sale 		$-5,160
-12,000 vol
$0.43 each 		-600,000
Filed 2018-04-26
Tx date 2018-04-25 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$87,000
+600,000 vol
$0.145 each 		0
Filed 2018-04-26
Tx date 2018-04-20 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-118,575
-255,000 vol
$0.465 each 		296,666
Filed 2018-04-26
Tx date 2018-04-25 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-87,000
-600,000 vol
$0.145 each 		5,130,206
Filed 2018-04-26
Tx date 2018-04-23 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
40 - Short sale 		$-12,397.50
-28,500 vol
$0.435 each 		-588,000
Filed 2018-04-26
Tx date 2018-04-23 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
40 - Short sale 		$-146,300
-332,500 vol
$0.44 each 		-559,500
Filed 2018-04-15
Tx date 2018-04-13 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$89,870
+619,794 vol
$0.145 each 		0
Filed 2018-04-15
Tx date 2018-04-13 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-89,870.13
-619,794 vol
$0.145 each 		5,730,206
Filed 2018-04-14
Tx date 2018-04-12 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
40 - Short sale 		$-90,549.06
-184,794 vol
$0.49 each 		-619,794
Filed 2018-04-14
Tx date 2013-06-10 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-14
Tx date 2018-04-11 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
40 - Short sale 		$-217,500
-435,000 vol
$0.50 each 		-435,000
Filed 2018-03-25
Tx date 2017-12-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Warrants
55 - Expiration of warrants
-75,000 vol
Filed 2018-03-25
Tx date 2017-12-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Warrants
55 - Expiration of warrants
-75,000 vol 		180,000
Filed 2018-03-23
Tx date 2017-12-01 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Warrants
55 - Expiration of warrants
-75,000 vol 		180,000
Filed 2017-04-03
Tx date 2017-03-31 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$520,000
+2,600,000 vol
$0.20 each 		6,350,000
Filed 2016-03-11
Tx date 2016-03-09 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$355,250
+2,450,000 vol
$0.145 each 		3,750,000
Filed 2015-07-24
Tx date 2015-07-13 		$ATE
Antibe Therapeutics Inc. 		Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$28,000
+200,000 vol
$0.14 each 		1,300,000